Filing Flows › Nexgel (NXGL) › Q3 2025
Nexgel (NXGL) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 12, 2025
Nexgel (NXGL) reported revenue of $2.9M for the third quarter 2025 (Q3 2025), -0.2% from a year earlier and +2% from the quarter before. Operating margin was -24.7%, net loss $647K (22.1% of revenue).
Nexgel, Q3 2025: revenue $2.9M (-0.2% year over year), operating margin -24.7%, net loss $647K, operating cash flow −$785K. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.9M | +2% | -0.2% |
| Operating profit | −$725K | — | — |
| Net earnings | −$647K | — | — |
| Operating cash flow | −$785K | — | — |
What changed
Revenue was $2.9M in Q3 2025, roughly flat year over year and up 2% from the previous quarter.
Gross margin was 42.4%, up 3.1 points from a year earlier. Operating costs exceeded revenue by $725K, an operating margin of -24.7%. Operating expenses grew 1% against flat revenue. The quarter ended with a net loss of $647K, wider than the previous quarter's $640K loss.
Operating cash flow was −$785K. Non-cash charges added back $113K of depreciation and amortization and $205K of share-based compensation. Working capital and other items used $456K. Capital expenditures of $8K exceeded it, leaving free cash flow of −$793K.
Questions
What was Nexgel's revenue in the third quarter 2025?
Nexgel (NXGL) reported revenue of $2.9M for the third quarter 2025 (Q3 2025), -0.2% from a year earlier and +2% from the quarter before.
Was Nexgel profitable in the third quarter 2025?
Operating loss was $725K (-24.7% of revenue) and net loss $647K.
Source: Nexgel 10-Q on SEC EDGAR.